Where the category stands in May 2026 — what's available, who to trust, what costs what. 22-min read, medically reviewed.
Read the guideAn independent overview of the compounded-GLP-1 telehealth market and the providers we cover — market size, what the FDA changed, and an honest read on each.
View the provider overviewOverview & reviewsPrimers for newcomers and deep dives for the curious. The foundation articles are published; more are in the pipeline.
View all Learn articlesWhat compounded and branded semaglutide and tirzepatide actually cost, from each provider's own published pricing.
PeptideWellness is an independent editorial guide to peptide therapy — GLP-1 medications, recovery and longevity peptides, and the telehealth and compounding-pharmacy providers that prescribe them. We cover one category closely, for readers making real decisions about their health and their money.
We explain the compounds, review the providers, and track the regulatory shifts that move the field — with claims sourced to primary references like FDA labels, ClinicalTrials.gov, and peer-reviewed journals. We cover FDA-approved peptide drugs and compounded peptides where the evidence supports honest discussion, and we stay away from the gray-market vendors that operate outside the compounding-pharmacy framework. How we source and evaluate is set out in our methodology; who writes and reviews the work is on our team and authors & medical review pages.
We don't take payment from the companies we cover in exchange for coverage, placement, or scoring, and we have no commercial relationship with any provider on the site. Provider coverage is decided by editorial judgment alone. The full statement, and how we'd handle any future change, is in our editorial policy.
Editorial note: this site is for informational purposes and does not constitute medical advice. Always consult a licensed healthcare provider familiar with your medical history. Compounded medications are not FDA-approved.